Clinical Trials Browser

Borderline Resectable Pancreatic Cancer

Stomach Neoplasms

Stomach Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Hepatocellular

Squamous Cell Carcinoma of Head and Neck

Anal Canal Carcinoma, Anus Neoplasms

Stomach Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Sinonasal Tumors

Unresectable Sinonasal Tumors

Colorectal Neoplasms

Keratosis, Actinic

Carcinoma, Hepatocellular

Head and Neck Neoplasms

Neoplasm Metastasis, Pancreatic Neoplasms

Carcinoma, Hepatocellular

Rectal Neoplasms

Esophageal Squamous Cell Carcinoma

Pancreatic Neoplasms

Pancreatic Cancer Non-resectable

MSI-H Advanced Colorectal Cancer

Bile Duct Neoplasms, Cholangiocarcinoma

Nasopharyngeal Carcinoma

High-risk Locally Advanced Colorectal Cancer

Carcinoma, Hepatocellular

Colorectal Cancer Metastatic

Colonic Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Stomach Neoplasms

Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

Stomach Neoplasms

Colorectal Neoplasms, Cholangiocarcinoma

Esophageal Squamous Cell Carcinoma

Pancreatic Neoplasms

Stomach Neoplasms

Elderly Metastatic Colorectal Cancer Patients

Rectal Neoplasms

Locally Advanced Rectal Cancer

Squamous Cell Carcinoma of Head and Neck

Stomach Neoplasms

Colorectal Neoplasms

Breast Neoplasms

Nasopharyngeal Carcinoma

Carcinoma, Hepatocellular

Clinical Trials

NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study

IMAGINE

Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer

FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma

AIO-KRK-0116

REVOLUTION

Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC

A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma

Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors

InterAACT

Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancer

Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer

HIPEC

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients

FIND

PACKS

Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma

Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer

FOOTPATH

HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC

Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer

Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC

MASTERPLAN

Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma

PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer

Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma

Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma

FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer

Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy

BEYOND

Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer

Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer

Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer

IRIGA

PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma

Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer

A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer

Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer

Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer

PANDA

FOTAC

Neoadjuvant mFOLFOXIRI Chemotherapy Alone for Extramural Vascular Invasion Positive Locally Advanced Rectal Cancer

Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC Patients

Neoadjuvant POF in the Treatment of Locally Advanced Gastric Cancer

CELIM2

MBC1

Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC